Search
for
Sort by
Research 30 of 703
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Rosacea and Rosacea-like Demodicldosis
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous Reactions to Drugs
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Secondary Syphilis in a 12-Year-Old Girl Misdiagnosed as Pityriasis lichenoides et varioliformis acuta: A Case Report
- Folliculocentric papules and alopecia
- Drug Eruptions
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Extensive scarring alopecia and widespread rash
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Cutaneous Lupus Erythematosus
- Acute Hair Loss 3 Years after Bone Marrow Transplant
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Dermatolojik Problemler ve COVID-19
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- British Society for Dermatopathology
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Frontal Fibrosing Alopecia
- Rare and common manifestations of COVID‐19 in children
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- A rare coexistence of alopecia areata and lichen planus
- Prophylaxis and Management of Skin Toxicities
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Cutaneous manifestations associated with immune checkpoint inhibitors